Antitumoral Agent-Induced Constipation: A Systematic Review
Open Access
Abstract
Background: Constipation is a common symptom in patients receiving antitumoral treatment. The mechanisms underlying antitumoral agent-induced constipation (ATAIC) are poorly defined. This systematic review aimed to analyze and synthesize the available information related to the prevalence, etiology, and treatment of ATAIC. Methods: A systematic review following the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines was conducted. The review included human studies written in English, French, or Spanish involving patients with cancer and containing information about the prevalence, etiology, and treatment of ATAIC. Results: A total of 73 articles were included. The reported prevalence ranged from 0.8% to 86.6%. Six studies reported an ATAIC prevalence of over 50%. The prevalence rates of constipation of grades 3 and 4 ranged between 0 and 11%. The importance of enteric neuronal integrity in gastrointestinal function was reported. The articles with the highest levels of evidence in relation to ATAIC treatment obtained in this systematic review studied treatments with acupuncture, sweet potato, osteopath, probiotics, and moxibustion. Conclusions: The prevalence of constipation in patients undergoing antitumoral treatment is very diverse. Studies specifically designed to report the prevalence of antineoplastic treatment-induced constipation are needed. The importance of enteric neuronal integrity in gastrointestinal function was described. Thus, neuroprotection could be an area of research for the treatment of chemotherapy-induced gastrointestinal disorders.Keywords
This publication has 86 references indexed in Scilit:
- Constipation in Palliative Care: What Do We Use as Definitions and Outcome Measures?Journal of Pain and Symptom Management, 2013
- Colonic Methane Production Modifies Gastrointestinal Toxicity Associated With Adjuvant 5-Fluorouracil Chemotherapy for Colorectal CancerJournal of Clinical Gastroenterology, 2013
- GRADE guidelines: 4. Rating the quality of evidence—study limitations (risk of bias)Journal of Clinical Epidemiology, 2011
- Symptom Prevalence and Longitudinal Follow-Up in Cancer Outpatients Receiving ChemotherapyJournal of Pain and Symptom Management, 2009
- Inflammatory Enteric Neuropathy With Severe Constipation After Ipilimumab Treatment for MelanomaJournal of Immunotherapy, 2009
- Gastrointestinal complications of oncologic therapyNature Clinical Practice Gastroenterology & Hepatology, 2008
- Gastrointestinal Side Effects Associated With Novel Therapies in Patients With Multiple Myeloma: Consensus Statement of the IMF Nurse Leadership BoardClinical Journal of Oncology Nursing, 2008
- Cancer Treatment, Symptom Monitoring, and Self-care in AdultsCancer Nursing, 2006
- Cancer chemotherapy-induced diarrhoea and constipation: mechanisms of damage and prevention strategiesSupportive Care in Cancer, 2006
- Patients' experiences of chemotherapy: side-effects of carboplatin in the treatment of carcinoma of the ovaryEuropean Journal of Cancer Care, 1997